{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:25:15Z","timestamp":1788323115291,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T00:00:00Z","timestamp":1704585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007152","name":"VIVUS Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.obpill.2024.100099","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T11:53:03Z","timestamp":1704714783000},"page":"100099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of phentermine \/ topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-1408","authenticated-orcid":false,"given":"Harold E.","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2832-3429","authenticated-orcid":false,"given":"Daniel S.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4421-7009","authenticated-orcid":false,"given":"Craig A.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6962-8803","authenticated-orcid":false,"given":"Santosh T.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2024.100099_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2023.100083","article-title":"Obesity and hypertension: obesity medicine association (OMA) clinical practice statement (CPS) 2023","volume":"8","author":"Clayton","year":"2023","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2024.100099_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.obpill.2024.100099_bib3","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/HYP.0000000000000202","article-title":"Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the American heart association","volume":"78","author":"Hall","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.obpill.2024.100099_bib4","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1586\/erc.10.125","article-title":"Phentermine, topiramate and their combination for the treatment of adiposopathy (\u2019sick fat\u2019) and metabolic disease","volume":"8","author":"Bays","year":"2010","journal-title":"Expet Rev Cardiovasc Ther"},{"key":"10.1016\/j.obpill.2024.100099_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2005.03.053","article-title":"Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension","volume":"96","author":"Tonstad","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.obpill.2024.100099_bib6","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1007\/s12325-023-02586-y","article-title":"Narrative review of topiramate: clinical uses and pharmacological considerations","volume":"40","author":"Pearl","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.obpill.2024.100099_bib7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","article-title":"Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness","volume":"102","author":"Leaf","year":"1985","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.obpill.2024.100099_bib8","article-title":"Obesity pillars roundtable: phentermine - Past, present, and future","volume":"3","author":"Bays","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2024.100099_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100342","article-title":"Ten things to know about ten cardiovascular disease risk factors - 2022","volume":"10","author":"Bays","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.obpill.2024.100099_bib9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2024.100099_bib11","article-title":"Obesity Pillars roundtable: excessive weight reduction with highly effective anti-obesity medications (heAOMs)","volume":"4","author":"Bays","year":"2022","journal-title":"Obes Pillars"},{"issue":"2","key":"10.1016\/j.obpill.2024.100099_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"9774","key":"10.1016\/j.obpill.2024.100099_bib21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.obpill.2024.100099_bib22","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.2337\/dc14-0930","article-title":"Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release","volume":"37","author":"Garvey","year":"2014","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.obpill.2024.100099_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.2204","article-title":"A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine\/topiramate for the treatment of obstructive sleep apnea in obese adults","volume":"35","author":"Winslow","year":"2012","journal-title":"Sleep"},{"issue":"16","key":"10.1016\/j.obpill.2024.100099_bib24","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.107.697086","article-title":"Ambulatory blood pressure for cardiovascular risk stratification","volume":"115","author":"Verdecchia","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.obpill.2024.100099_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/oby.22430","article-title":"Safety and Effectiveness of Longer-Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort","volume":"27","author":"Lewis","year":"2019","journal-title":"Obesity (Silver Spring, Md)"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368124000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368124000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:20:05Z","timestamp":1762644005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368124000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":17,"alternative-id":["S2667368124000019"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2024.100099","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of phentermine \/ topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2024.100099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100099"}}